Literature DB >> 31949120

Impact of BAL lymphocytosis and presence of honeycombing on corticosteroid treatment effect in fibrotic hypersensitivity pneumonitis: a retrospective cohort study.

Laurens J De Sadeleer1,2, Frederik Hermans1, Els De Dycker1, Jonas Yserbyt1, Johny A Verschakelen3, Eric K Verbeken4, Geert M Verleden1,2, Stijn E Verleden2, Wim A Wuyts1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 31949120     DOI： 10.1183/13993003.01983-2019

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  11 in total

Review 1.  Hypersensitivity pneumonitis.

Authors:  Ulrich Costabel; Yasunari Miyazaki; Annie Pardo; Dirk Koschel; Francesco Bonella; Paolo Spagnolo; Josune Guzman; Christopher J Ryerson; Moises Selman
Journal:  Nat Rev Dis Primers       Date:  2020-08-06       Impact factor: 52.329

2.  Effect of Oral Methyl Prednisolone on Different Radiological Patterns of Hypersensitivity Pneumonitis.

Authors:  Fatma Ahmed Tony; Youssef Mohamed Amin Soliman; Hoda A Salem
Journal:  J Asthma Allergy       Date:  2021-05-10

3.  Lung Microenvironments and Disease Progression in Fibrotic Hypersensitivity Pneumonitis.

Authors:  Laurens J De Sadeleer; John E McDonough; Jonas C Schupp; Xiting Yan; Arno Vanstapel; Anke Van Herck; Stephanie Everaerts; Vincent Geudens; Annelore Sacreas; Tinne Goos; Celine Aelbrecht; Tim S Nawrot; Dries S Martens; Dominique Schols; Sandra Claes; Johny A Verschakelen; Eric K Verbeken; Maximilian Ackermann; Anabelle Decottignies; Manon Mahieu; Tillie-Louise Hackett; James C Hogg; Bart M Vanaudenaerde; Stijn E Verleden; Naftali Kaminski; Wim A Wuyts
Journal:  Am J Respir Crit Care Med       Date:  2022-01-01       Impact factor: 21.405

4.  Real-life prevalence of progressive fibrosing interstitial lung diseases.

Authors:  Maureen Gagliardi; Damienne Vande Berg; Charles-Edouard Heylen; Sandra Koenig; Delphine Hoton; Farah Tamirou; Thierry Pieters; Benoit Ghaye; Antoine Froidure
Journal:  Sci Rep       Date:  2021-12-14       Impact factor: 4.379

Review 5.  Monitoring and management of fibrosing interstitial lung diseases: a narrative review for practicing clinicians.

Authors:  Anoop M Nambiar; Christopher M Walker; Jeffrey A Sparks
Journal:  Ther Adv Respir Dis       Date:  2021 Jan-Dec       Impact factor: 5.158

6.  Challenges in the Diagnosis and Management of Patients with Fibrosing Interstitial Lung Disease.

Authors:  Leslie B Tolle
Journal:  Case Rep Pulmonol       Date:  2022-02-15

7.  Management and support of patients with fibrosing interstitial lung diseases.

Authors:  Tyonn Barbera; Lesley Davila; Nina M Patel
Journal:  Nurse Pract       Date:  2021-07-01

Review 8.  Challenges in the Diagnosis and Management of Fibrotic Hypersensitivity Pneumonitis: A Practical Review of Current Approaches.

Authors:  Teng Moua; Tananchai Petnak; Antonios Charokopos; Misbah Baqir; Jay H Ryu
Journal:  J Clin Med       Date:  2022-03-08       Impact factor: 4.241

9.  Bronchoalveolar lavage lymphocytosis in hypersensitivity pneumonitis: a retrospective cohort analysis with elimination of incorporation bias.

Authors:  Meghan Hill; Tananchai Petnak; Teng Moua
Journal:  BMC Pulm Med       Date:  2022-02-01       Impact factor: 3.317

Review 10.  A contemporary practical approach to the multidisciplinary management of unclassifiable interstitial lung disease.

Authors:  Christopher J Ryerson; Tamera J Corte; Jeffrey L Myers; Simon L F Walsh; Sabina A Guler
Journal:  Eur Respir J       Date:  2021-12-16       Impact factor: 16.671
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.